Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
Conditions: Gallbladder Cancer; Initially Unresectable; the First Line Treatment Intervention: Drug: Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab Sponsor: Lu Wang, MD, PhD Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials